Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation

Transplant Proc. 2002 Sep;34(6):2253-5. doi: 10.1016/s0041-1345(02)03224-4.
No abstract available

MeSH terms

  • Adult
  • Age of Onset
  • Diabetes Mellitus, Type 1 / surgery
  • Diabetic Nephropathies / surgery
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Graft Rejection / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*
  • Pancreas Transplantation / immunology*
  • Renal Dialysis
  • Retrospective Studies
  • Sirolimus / therapeutic use*
  • Steroids / therapeutic use
  • Time Factors
  • Tissue Donors / statistics & numerical data

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Steroids
  • Sirolimus